Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
The Government will adopt the list of risk level of places in the Mainland published by the National Health Commission from May 25 and upload the list of medium or high-risk Mainland areas to the Return2hk Scheme thematic website.
It said it has maintained close communication and liaison with the Mainland authorities on COVID-19 epidemic prevention and control measures of both places.
Hong Kong residents who have visited any area in the Mainland being classified as a medium or high-risk area on the list on the scheme's website in the past 14 days prior to and upon the day of arrival in Hong Kong will not be exempted from compulsory quarantine under the scheme upon their entry into the city.
http://dlvr.it/S0M6X2
http://dlvr.it/S0M6X2